ArticleBioinformation2026
Effect of autologous platelet-rich fibrin on implant stability and crestal bone levels in the maxilla - An observational study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early implant stability and crestal bone preservation remain critical challenges for successful maxillary implant placement in D3 bone density, requiring effective adjunctive therapies. This study compared 30 maxillary implants across PRF-assisted and control groups, evaluating implant stability quotient (ISQ) values and crestal bone alterations over two months post-placement. The PRF group demonstrated significantly higher ISQ values and minimal crestal bone loss compared to controls (p < 0.05), indicating enhanced early osseointegration. PRF effectively supported implant primary stability while preserving surrounding bone architecture during the critical initial healing phase. These findings establish PRF as a valuable adjunctive therapy for optimizing early outcomes in challenging maxillary D3 bone conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.